Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Omrix Biopharmaceuticals has appointed Larry Ellberger as the chairman of the board of directors and Pamela McNamara as director of the company.
Subscribe to our email newsletter
Mr Ellberger succeeds Fredric Price who served as Omrix’s chairman from January 2005. Mr Ellberger has been a member of the company’s board since August 2006 and was previously chairman of the compensation committee. He will continue to be a member of the audit committee and will chair the governance and nominating committee.
Ms McNamara will chair the compensation committee and be a member of the audit committee. Ms McNamara has been CEO of CRF, a clinical trial data management and mobile technology company, since October 2003.